28.1 C
Delhi
Friday, July 19, 2024

Extravagant weddings: The hidden costs of lavish celebrations

How fancy weddings widen social and economic...

Union Minister Piyush Goyal has announced substantial concessions in licensing fees

Union Minister Piyush Goyal has announced substantial...

Licences of 18 pharma firms cancelled for manufacturing bogus drugs

EconomyLicences of 18 pharma firms cancelled for manufacturing bogus drugs

26 firms have been given show-cause notices and the Licences of 18 pharma firms cancelled for manufacturing spurious drugs

There were inspections carried out across 20 states and Union territories in the past 15 days and in a major crackdown against the manufacture of substandard drugs, central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them for producing spurious and adulterated drugs, official sources said on Tuesday. The names of the companies are not yet known.

“Licences of 18 pharma companies have been cancelled for manufacturing spurious and adulterated drugs and for violating GMP (good manufacturing practice)…. Besides, 26 firms have been given show-cause notices and the product permission of three firms have been also cancelled,” the source said.

As part of the special drive, the regulators have identified 203 firms. A majority of the companies are from Himachal Pradesh (70), followed by Uttarakhand (45) and Madhya Pradesh (23), sources said.

More such inspections will follow in the coming days, they said.  Recently, questions have been raised over the quality of drugs manufactured by India-based companies. In February, the Tamil Nadu-based Global Pharma Healthcare recalled its entire lot of eye drop allegedly linked to vision loss in the US.

Before that, India-made cough syrups were allegedly linked to child deaths in the Gambia and Uzbekistan last year.

Check out our other content

Check out other tags:

Most Popular Articles